We observed that G3BP1 expression gradually increased in tissue samples of benign to primary PCa tumors and was most abundant in Castration-resistance prostate cancer (CRPC), suggesting that G3BP1 overexpression is associated with more aggressive disease across the clinical spectrum of prostate cancer. The gene discussed is G3BP1; the disease is prostate cancer.